Iris Acquisition Corp II is a blank check company.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$10.04 – $10.06
Volume2
Market cap$230M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for IRAB.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for IRAB.
Recent news
Company coverage with links to the original publishers.
DIAGNOS announced a flash report highlighting progress toward regulatory approvals for its CARA AI platform from Health Canada, FDA, and SFDA. The company has assessed over 400,000 patients across 140 clinics and maintains partnerships with major optical industry players. An independent market study projects the global AI-powered retinal image analysis market could grow from US$2.65 billion in 2023 to US$9.4 billion by 2033.
Iris Acquisition Corp II (NYSE: IRAB) announced a non-binding letter of intent to combine with Freedom Metals Corporation, a new entity to be formed by American Tungsten & Antimony Ltd (ASX: AT4). The combined company will focus on developing U.S.-based antimony and tungsten projects to address critical mineral supply chain needs for defense and industrial applications. The transaction remains subject to definitive agreements, due diligence, and shareholder approval.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.